Coherus Biosciences | CHRS - Borç Faiz Gideri





Borç Faiz Gideri Değişiklik Tarih
AbbVie USD 688M 58M 2026-09
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Akebia Therapeutics 342.13M 7.53M 2026-09
ALKERMES USD 27.55M 1.63M 2026-09
Alnylam Pharmaceuticals USD -84.37M 166.42M 2026-09
Amarin USD 3K 5K 2024-12
Amgen USD 653M 94.99B 2026-09
Baxter International USD 64M 14M 2026-06
Biogen USD 72.6M 12.6M 2025-06
BioMarin Pharmaceutical USD 55.63M 7.67M 2026-09
Bristol-Myers Squibb USD 403M 4M 2026-09
Coherus Biosciences USD 2.25M 76K 2025-12
Eli Lilly USD 316M 201.3M 2026-09
Fujifilm JPY 2.46B 1.6B 2026-09
Gilead Sciences USD 269M 22M 2026-09
Ironwood Pharmaceuticals USD 8.74M 506K 2024-12
Merck USD 525M 46M 2026-06
Myriad Genetics USD 4.4M 600K 2025-12
Pacira USD 112.4M 108.78M 2026-09
Perrigo USD 7.48B 124.6M 2026-09
Pfizer USD 662M 5M 2026-09
PTC Therapeutics USD 3.21B 42.76M 2026-09
Regeneron Pharmaceuticals USD 11M 1.9M 2026-06
Sarepta Therapeutics USD 21.51M 205K 2026-06
Teva Pharmaceutical Industries USD 414M 219M 2026-09
Vertex Pharmaceuticals USD 36M 32.7M 2026-09
Xencor USD 4.11M 3.24M 2026-09
Zoetis USD 62M 1000K 2026-09